Should labetalol and clonidine be held before general anesthesia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Perioperative Management of Labetalol and Clonidine

Beta blockers like labetalol and centrally-acting agents like clonidine should be continued through the perioperative period and not held before general anesthesia. 1

Rationale for Continuing These Medications

Beta Blockers (Labetalol)

  • Abrupt discontinuation of beta blockers preoperatively is potentially harmful (Class III: Harm, Level B-NR) 1
  • Can cause rebound hypertension, tachycardia, and increased risk of perioperative cardiovascular events 1
  • Patients who have been on beta blockers chronically should continue them throughout the perioperative period (Class I, Level B-NR) 1

Clonidine

  • Abrupt discontinuation of clonidine can cause dangerous rebound hypertension (Class III: Harm, Level B-NR) 1
  • Studies show that discontinuing clonidine before surgery can lead to hypertensive crisis in the recovery period 2
  • The FDA label for clonidine specifically states: "Administration of clonidine should be continued to within four hours of surgery and resumed as soon as possible thereafter" 3

Clinical Evidence and Consequences

For Labetalol:

  • Withdrawal can lead to:
    • Rebound hypertension
    • Tachycardia
    • Increased myocardial oxygen demand
    • Higher risk of perioperative ischemia and infarction 4
  • The FDA label notes that abrupt discontinuation should be avoided 4

For Clonidine:

  • Withdrawal syndrome can appear immediately after anesthesia if discontinued on the operation day 2
  • Symptoms include nervousness, agitation, headache, tremor, and rapid rise in blood pressure 3
  • Rare but serious consequences include hypertensive encephalopathy, cerebrovascular accidents, and death 3
  • A study showed that 2 out of 10 patients who discontinued clonidine experienced hypertensive crisis during recovery 2

Perioperative Management Recommendations

  1. Continue both medications up to the day of surgery (Class IIa, C-EO) 1
  2. For clonidine: Continue administration to within four hours of surgery and resume as soon as possible afterward 3
  3. For labetalol: Continue through the perioperative period, especially if the patient has been on it chronically 1
  4. Intraoperative management: If needed, use intravenous medications to manage blood pressure until oral medications can be resumed 1

Potential Pitfalls and Caveats

  • Do not start beta blockers on the day of surgery in beta blocker-naïve patients (Class III: Harm, Level B-NR) 1
  • Monitor for hypotension during anesthesia induction, especially with labetalol, and have vasopressors readily available 5
  • Consider dose adjustment rather than discontinuation if concerned about intraoperative hypotension 6
  • For patients on both beta blockers and clonidine: Extra vigilance is required as the combination can potentiate bradycardia and hypotension 3

Special Considerations

  • While ACE inhibitors and ARBs may be discontinued 24 hours before surgery (Class IIb, B-NR), this recommendation does not apply to beta blockers or clonidine 1, 7
  • If severe hypertension exists (SBP ≥180 mmHg or DBP ≥110 mmHg), consider deferring elective surgery rather than adjusting chronic medications 1
  • Ensure that these medications are resumed as soon as possible postoperatively 6

In summary, the evidence strongly supports continuing both labetalol and clonidine through the perioperative period to avoid potentially dangerous withdrawal syndromes and cardiovascular complications.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Perioperative Management of Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.